site stats

Evofem financials

WebGet the latest Evofem Biosciences Inc (EVFM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. WebLegal Name Evofem Biosciences, Inc. Stock Symbol NASDAQ:EVFM. Company Type For Profit. Contact Email [email protected]. Phone Number +858.550.1900. Evofem is a biopharmaceutical company that offers women's reproductive and contraceptive care products. The company's first commercial product, Phexxi, is the first and only hormone …

Evofem Biosciences Announces $10 Million Registered Direct Offering of ...

WebMar 9, 2024 · Evofem Biosciences, Inc. (OTCQB: EVFM) is pleased to announce the appointment of Albert Altro as Interim Chief Financial Officer of the Company. He replaces Jay File, who is leaving the Company to ... WebFeb 17, 2024 · Item 1.01. Entry into Material Definitive Agreement. Securities Purchase Agreement. On February 17, 2024, Evofem Biosciences, Inc., a Delaware corporation (the "Company"), entered into a securities purchase agreement ("SPA"), with certain investors (the "Investors") providing for the sale and issuance of senior subordinate convertible … taverniti clothing https://21centurywatch.com

Evofem Biosciences - Funding, Financials, Valuation

WebEVOFEM BIOSCIENCES, INC. EVOFEM BIOSCIENCES, INC. 0.42 ‎-5.94%. 0.42. at close ‎-0.03 (‎-5.94%) ... Financial Leverage. When assets to equity is a low ratio, it means the company has chosen ... WebMar 9, 2024 · Evofem Biosciences, Inc. Mar 09, 2024, 06:50 ET. SAN DIEGO, March 9, 2024 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) is pleased to announce the appointment of Albert Altro as Interim ... WebGet the detailed quarterly/annual income statement for Evofem Biosciences, Inc. (EVFM). Find out the revenue, expenses and profit or loss over the last fiscal year. Find the latest Evofem Biosciences, Inc. (EVFM) stock discussion in Yahoo … Find out the direct holders, institutional holders and mutual fund holders for … Interactive Chart for Evofem Biosciences, Inc. (EVFM), analyze all the data with a … View the basic EVFM option chain and compare options of Evofem … Find out all the key statistics for Evofem Biosciences, Inc. (EVFM), including … See Evofem Biosciences, Inc. (EVFM) stock analyst estimates, including earnings … Evofem Biosciences, Inc. 12400 High Bluff Drive Suite 600 San Diego, CA 92130 … taverniti jeans where to buy

EVFM : EVOFEM BIOSCIENCES, INC. - MSN Money

Category:Evofem Appoints Ivy Zhang as Chief Financial Officer and …

Tags:Evofem financials

Evofem financials

Evofem Biosciences - Funding, Financials, Valuation & Investors

WebApr 14, 2024 · SAN DIEGO, April 14, 2024--Evofem Biosciences, Inc., (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced the appointment of Ivy Zhang as Chief Financial Officer (CFO) and Secretary, effective April 13, 2024.Reporting to Chief Executive Officer Saundra Pelletier, Ms. Zhang will lead … WebEvofem Biosciences Inc. SEC filings breakout by MarketWatch. View the EVFM U.S. Securities and Exchange Commission reporting information.

Evofem financials

Did you know?

WebJan 17, 2024 · Evofem Biosciences has raised a total of $470.8M in funding over 16 rounds. Their latest funding was raised on May 20, 2024 from a Post-IPO Equity round. Evofem … WebOct 12, 2024 · The securities described above are being offered and sold only by means of a written prospectus and related prospectus supplement forming part of Evofem's shelf registration statement on Form S-3 ...

WebApr 14, 2024 · SAN DIEGO , April 14, 2024 /PRNewswire/ --Evofem Biosciences, Inc., (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced the appointment of Ivy Zhang as Chief Financial Officer (CFO) and Secretary, effective April 13, 2024.Reporting to Chief Executive Officer Saundra Pelletier, … WebDec 22, 2024 · Evofem Biosciences Inc. SEC filings breakout by MarketWatch. View the EVFM U.S. Securities and Exchange Commission reporting information.

WebApr 10, 2024 · Evofem Biosciences Announces Strong Second Quarter 2024 Financial Results and Affirms 2024 Guidance -- 42% growth in Phexxi® (lactic acid, citric acid and … WebApr 14, 2024 · Evofem Biosciences, Inc., (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced the appointment of Ivy Zhang as Chief Financial Officer (CFO ...

Web2 days ago · In the first quarter of 2024, Evofem gained Phexxi coverage for 16.3 million new lives from payers including Mississippi Medicaid, Indiana State Medicaid, multiple Blue Cross Blue Shield plans ...

WebEvofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced it has implemented measures to lower its operating expenses, with the goal of reaching cash … the catch fish and chips sudbury hillWebApr 10, 2024 · EVOFEM BIOSCIENCES, INC. ... The Company and each of its Subsidiaries maintains internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the 1934 Act) that is ... taverniti relaxed straight legWebMar 6, 2024 · Item 1.01 Entry into a Material Definitive Agreement. Securities Purchase Agreement. On March 13, 2024, Evofem Biosciences, Inc., a Delaware corporation (the "Company"), entered into a securities purchase agreement ("SPA"), effective March 6, 2024, with certain investors (the "Investors") providing for the sale and issuance of senior … taverniti oficialWebApr 14, 2024 · SAN DIEGO , April 14, 2024 /PRNewswire/ --Evofem Biosciences, Inc., (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), … tavern island soldWeb6 minutes ago · SAN DIEGO , April 14, 2024 /PRNewswire/ -- Evofem Biosciences, Inc. , (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced the appointment of Ivy Zhang as Chief Financial Officer (CFO) and Secretary, effective April 13, 2024.Reporting to Chief Executive Officer Saundra Pelletier … tavern keyworth facebookWebApr 6, 2024 · 62,6%. More Financials. Company. Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from … the catch fishing guide redditWebMar 10, 2024 · SAN DIEGO, March 3, 2024 - Evofem Biosciences, Inc. (Nasdaq: EVFM), a commercial stage biopharmaceutical company, today reported financial results for the three- and twelve-month periods ended December 31, 2024. "In our first full year as a commercial company Evofem delivered strong growth, capped by an exceptional fourth … the catch fishes needed